144 related articles for article (PubMed ID: 7622828)
1. Is intermittent, early intervention medication an alternative for neuroleptic maintenance treatment?
Gaebel W
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 5():11-6. PubMed ID: 7622828
[TBL] [Abstract][Full Text] [Related]
2. Intermittent medication--an alternative?
Gaebel W
Acta Psychiatr Scand Suppl; 1994; 382():33-8. PubMed ID: 7916527
[TBL] [Abstract][Full Text] [Related]
3. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies.
Gaebel W; Jänner M; Frommann N; Pietzcker A; Köpcke W; Linden M; Müller P; Müller-Spahn F; Tegeler J
Schizophr Res; 2002 Jan; 53(1-2):145-59. PubMed ID: 11728846
[TBL] [Abstract][Full Text] [Related]
4. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?
Gaebel W; Frick U; Köpcke W; Linden M; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
Br J Psychiatry Suppl; 1993 Sep; (21):8-12. PubMed ID: 8105814
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
McGrath JJ; Soares KV
Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic low-dose long-term strategy and intermittent therapy strategy in chronic schizophrenia--a critical review].
Hofmann P; Melisch B; Zapotoczky HG; Kulhanek F
Fortschr Neurol Psychiatr; 1993 Jun; 61(6):195-200. PubMed ID: 8101177
[TBL] [Abstract][Full Text] [Related]
7. The routine use of atypical antipsychotic agents: maintenance treatment.
Kinon BJ
J Clin Psychiatry; 1998; 59 Suppl 19():18-22. PubMed ID: 9847048
[TBL] [Abstract][Full Text] [Related]
8. Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia.
Caroff SN; Mu F; Ayyagari R; Schilling T; Abler V; Carroll B
BMC Psychiatry; 2018 Sep; 18(1):306. PubMed ID: 30249218
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
Soares-Weiser K; Rathbone J
Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
[TBL] [Abstract][Full Text] [Related]
10. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years.
Jolley AG; Hirsch SR; Morrison E; McRink A; Wilson L
BMJ; 1990 Oct; 301(6756):837-42. PubMed ID: 2282421
[TBL] [Abstract][Full Text] [Related]
11. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.
De Hert M; Sermon J; Geerts P; Vansteelandt K; Peuskens J; Detraux J
CNS Drugs; 2015 Aug; 29(8):637-58. PubMed ID: 26293744
[TBL] [Abstract][Full Text] [Related]
12. Early intervention, time-limited, targeted pharmacotherapy of schizophrenia.
Carpenter WT; Heinrichs DW
Schizophr Bull; 1983; 9(4):533-42. PubMed ID: 6140752
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.
Shriqui CL
Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S38-48. PubMed ID: 8564916
[TBL] [Abstract][Full Text] [Related]
14. Prediction of relapse in schizophrenia.
Lieberman JA; Kane JM; Sarantakos S; Gadaleta D; Woerner M; Alvir J; Ramos-Lorenzi J
Arch Gen Psychiatry; 1987 Jul; 44(7):597-603. PubMed ID: 2886110
[TBL] [Abstract][Full Text] [Related]
15. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.
Jolley AG; Hirsch SR; McRink A; Manchanda R
BMJ; 1989 Apr; 298(6679):985-90. PubMed ID: 2567190
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
17. The early course of schizophrenia and long-term maintenance neuroleptic therapy.
Nuechterlein KH; Gitlin MJ; Subotnik KL
Arch Gen Psychiatry; 1995 Mar; 52(3):203-5. PubMed ID: 7872846
[No Abstract] [Full Text] [Related]
18. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine in the long-term treatment of schizophrenia.
Kane J
Br J Psychiatry Suppl; 1999; (37):26-9. PubMed ID: 10211138
[TBL] [Abstract][Full Text] [Related]
20. Intermittent vs maintenance medication in schizophrenia. Two-year results.
Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J
Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
